Kedves Kollégák!
Kérjük, amennyiben lehetőségük van rá, az alábbi felmérés kitöltésével segítsék munkánkat. A kérdőív angol nyelvű, a válaszadás mindössze pár percet vesz igénybe. A reprezentatív eredmény eléréséhez, minél nagyobb részvételi arány szükséges. Együttműködésüket köszönjük!
Dear colleague,
Methotrexate (MTX) is still our anchor drug used in Patients with Rheumatoid Arthritis. Nevertheless, the prescription patterns of MTX vary across centres and countries. As part of Horizon Europe project SQUEEZE, we aim to assess local practice of methotrexate (MTX) initiation and titration scheme in patients with rheumatoid arthritis (RA) across Europe.
We are inviting all physicians treating patients with rheumatoid arthritis across different European countries and hospital/practice settings to take part in this survey.
It will take approximately 10-15 minutes to complete the survey. You can save and return to your answers at any time (if you are not able to finish it at one time point or if you want to correct some of your responses). Please note the link needs to be completed from the same computer, if you want to fill out more than one survey this needs to be done on different computers. Please make sure you do not leave the survey half completed. We would like to emphasize that there are no right or wrong answers.
You can contribute to research by simply using the link: https://de.surveymonkey.com/r/F7Q6LY3
